2008
DOI: 10.1086/588733
|View full text |Cite
|
Sign up to set email alerts
|

Human T Lymphotropic Virus Type 1 Infection and Gastric Cancer Development in Japan

Abstract: HTLV-1 infection likely reduces the risk of H. pylori infection and proliferation and, thereby, the risk of gastric cancer.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

1
16
0
1

Year Published

2008
2008
2021
2021

Publication Types

Select...
5
2

Relationship

0
7

Authors

Journals

citations
Cited by 20 publications
(18 citation statements)
references
References 19 publications
1
16
0
1
Order By: Relevance
“…Could there be an interaction between HTLV-1 and H. pylori? This study and several previous studies provide evidence that HTLV-1–positive hosts carry H. pylori less often than do HTLV-1-negative hosts [1, 4, 5]. Thus, one potential explanation is that the immunological context created by HTLV-1 is inhibitory to H. pylori .…”
supporting
confidence: 69%
See 3 more Smart Citations
“…Could there be an interaction between HTLV-1 and H. pylori? This study and several previous studies provide evidence that HTLV-1–positive hosts carry H. pylori less often than do HTLV-1-negative hosts [1, 4, 5]. Thus, one potential explanation is that the immunological context created by HTLV-1 is inhibitory to H. pylori .…”
supporting
confidence: 69%
“…In this issue of the Journal, Matsumoto et al [1] asked whether human T lymphotropic virus type 1 (HTLV-1) antibody status is associated with the risk of developing gastric cancer. In a cohort of >5000 patients aged >40 years who were enrolled during 1989–1992 in an HTLV-1–endemic area, they identified 1812 subjects who underwent endoscopy of the upper gastrointestinal tract before 2003.…”
mentioning
confidence: 99%
See 2 more Smart Citations
“…If infections during the first year of life are a genuine factor, our findings may imply that in Mexico City these peaks have different etiologies with infection being more important for the 6 -9 years age group. The relevant agents may be viewed as having an indirect leukemogenic effect, as in situations reported in relation to cancer in adults (Matsumoto et al, 2008).…”
Section: Discussionmentioning
confidence: 99%